HOUSE-BILL 946: H.R.946 - ORPHAN Cures Act
AI-Powered Summary
HOUSE-BILL 946, titled the 'ORPHAN Cures Act', aims to amend the Drug Price Negotiation Program by expanding the exclusion criteria for orphan drugs, which are essential for individuals with rare diseases. The legislation addresses major themes such as healthcare access, pharmaceutical pricing, and the balance between innovation and affordability. Key provisions include a clarification of orphan drug definitions to encompass those for one or more rare diseases, and adjustments to the drug approval timeline calculations that may facilitate more orphan drugs entering the negotiation process. Implementation of these changes is expected to enhance access to necessary treatments for affected individuals, though there are concerns about potential increases in drug prices that could disproportionately impact low-income populations. Overall, the bill seeks to improve the availability and affordability of critical medications while navigating the complexities of healthcare rights and pharmaceutical market dynamics.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
HOUSE-BILL 946 aims to enhance access to orphan drugs, which could improve health outcomes for individuals with rare diseases. However, the potential for unequal access based on demographic factors introduces ambiguity regarding its constitutional alignment.
Key Individual Rights Affected
Positive
- Right to Health Care Access
- Equal Protection under the Law
Negative
- Potential Disparities in Access
- Impact on Future Drug Development
Constitutional Provisions
- 14th Amendment - Equal Protection Clause
- Commerce Clause
Potential Constitutional Challenges
- Disparities in access to medications for marginalized groups could lead to equal protection challenges.
- Concerns regarding the bill's impact on pharmaceutical innovation may raise questions about the right to health care access.
Summary
While HOUSE-BILL 946 seeks to improve access to orphan drugs, its implications for individual rights, particularly regarding equal protection and health care access, are complex and may require further scrutiny to ensure that it does not disproportionately disadvantage vulnerable populations.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 946 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreePolicy Topics
Timeline
February 4, 2025
Bill Introduced
Current
Introduced
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat